Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MicroflowLife

Financiado

Cerrado

Whole-organ 3D ultrasound micro-flow imaging: from basics physics to clinical pr...

Whole-organ 3D ultrasound micro-flow imaging: from basics physics to clinical proof-of-concept on cardiac and cerebral diseases Blood circulation is essential to organs’ functions and occurs through a complex network of vessels with diameters varying from several millimetres for large arteries to only a few microns for small capillaries. Dysfunctions in th... ver más

31/08/2027

INSERM

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHER... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-07-12

ERC-2021-STG: ERC STARTING GRANTS Scope:Objectives

I+D

Cerrada hace 3 años

0% 100% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

INSERM

1.50M€ | Lider

Proyectos interesantes

ResolveStroke

Medical Technol...

Applied Physics

2M€ Cerrado

SEFC

Medical Technol...

Applied Physics

164K€ Cerrado

AXES.Histo

Medical Technol...

Applied Physics

2M€ Cerrado

ANATOMY-FOUND

Medical Technol...

Applied Physics

200K€ Cerrado

SURE

Medical Technol...

Applied Physics

10M€ Cerrado

BIO2008-06843-C04-01

Medical Technol...

Applied Physics

121K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 61 meses Fecha Inicio: 2022-07-12
Fecha Fin: 2027-08-31

Líder del proyecto

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHER... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Blood circulation is essential to organs’ functions and occurs through a complex network of vessels with diameters varying from several millimetres for large arteries to only a few microns for small capillaries. Dysfunctions in the microcirculation are early markers of many diseases, which are however diagnosed at later stage, when observable symptoms become visible at larger scales. Mapping blood flows across several spatial scales at depth in organs is therefore crucial for early diagnosis and monitoring of diseases, but it remains a major challenge in clinical medical imaging. Our laboratory Physics for Medicine Paris has introduced in 2015 ultrasound localization microscopy (ULM), a non-invasive method to map and quantify blood flows at depth in organs down to a micron scale resolution, opening avenues for medical imaging. However, 2D ULM is highly operator-dependent because probe positioning is critical to view the appropriate cross-section. Imaging the whole-organ in 3D is therefore crucial for clinical practice, and for a comprehensive investigation of organ’s functions. Capturing large 3D volumes through the bones such as the skull or the rib cage is a further challenge in ultrasound imaging: acoustic energy losses due to reflection and distortion of ultrasound waves at the bone interface significantly reduce the imaging sensitivity. The objective of MicroflowLife is to develop ultrasensitive 3D ULM through bones for mapping the microcirculation of the whole-heart and the whole-brain. Our approach relies on the development of novel ultrasonic multi-lens probes, combined with new acquisition sequences and processing methods. Our technology and methods will be first validated in vitro and in vivo, and then translated clinically in first-in-human studies. Feasibility of cardiac and cerebral applications will be assessed in two morbid diseases associated with microcirculation alteration: coronary microvascular dysfunction and brain glioblastoma tumors.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores